华润双鹤: 华润双鹤关于控股股东股权结构变动的公告

Core Viewpoint - The equity structure change of the controlling shareholder, Beijing Pharmaceutical Group Co., Ltd. (North Pharmaceutical Group), does not alter the controlling shareholder or actual controller of China Resources Double Crane Pharmaceutical Co., Ltd. (China Resources Double Crane) [1][2] Group 1: Overview of the Change - The controlling shareholder of North Pharmaceutical Group has changed from China Resources Pharmaceutical Investment Co., Ltd. to China Resources Pharmaceutical Holdings Co., Ltd. after a transfer of 51% equity [1] - The change has been completed with the necessary business registration procedures [1] Group 2: Impact on the Company - The equity structure change will not lead to any changes in the controlling shareholder or actual controller of China Resources Double Crane [2] - The governance structure and operational activities of the company will remain unaffected by this change [2] Group 3: Additional Information - The equity change involves the disclosure obligations of China Resources Pharmaceutical Investment Co., Ltd., with detailed reports available on the Shanghai Stock Exchange website and in various financial newspapers [2]